Genetic determinants of intrinsic colistin tolerance in acinetobacter baumannii

Infection and Immunity

Volumn 81, Issue 2, 2013, Pages 542-551

  Hood, M Indriati ^a   Becker, Kyle W ^a   Roux, Christelle M ^b   Dunman, Paul M ^b   Skaar, Eric P ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIUM LIPOPOLYSACCHARIDE; COLISTIN; GLYCOSYLTRANSFERASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL OUTER MEMBRANE; CARBOHYDRATE SYNTHESIS; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; INNATE IMMUNITY; LOSS OF FUNCTION MUTATION; LUNG INFECTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSPOSON;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GLYCOSYLTRANSFERASES; IMMUNE TOLERANCE; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; LUNG; MANNOSYLTRANSFERASES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTATION; PNEUMONIA;

EID: 84873839930     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00704-12     Document Type: Article

References (40)

1. Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators. 2009. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323-2329.
2. Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, Pittet D. 2011. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 377:228-241.
3. Gaynes R, Edwards JR, National Nosocomial Infections Surveillance System. 2005. Overview of nosocomial infections caused by gramnegative bacilli. Clin. Infect. Dis. 41:848-854.
4. Srivastava S, Shetty N. 2007. Healthcare-associated infections in neonatal units: lessons from contrasting worlds. J. Hosp. Infect. 65:292-306.
5. Erdem I, Ozgultekin A, Sengoz Inan A, Dincer E, Turan G, Ceran N, Ozturk Engin D, Senbayrak Akcay S, Akgun N, Goktas P. 2008. Incidence, etiology, and antibiotic resistance patterns of gram-negative microorganisms isolated from patients with ventilator-associated pneumonia in a medical-surgical intensive care unit of a teaching hospital in Istanbul, Turkey (2004-2006). Jpn. J. Infect. Dis. 61:339-342.
6. Garza-González E, Llaca-Díaz JM, Bosques-Padilla FJ, González GM. 2010. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii. Chemotherapy 56:275-279.
7. Jean S-S, Hsueh P-R. 2011. High burden of antimicrobial resistance in Asia. Int. J. Antimicrob. Agents 37:291-295.
8. Apisarnthanarak A, Mundy LM. 2009. Mortality associated with pandrug- resistant Acinetobacter baumannii infections in Thailand. Am. J. Infect. Control 37:519-520.
9. Chan P-C, Huang L-M, Lin H-C, Chang L-Y, Chen M-L, Lu C-Y, Lee P-I, Chen J-M, Lee C-Y, Pan H-J, Wang J-T, Chang S-C, Chen Y-C. 2007. Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol. 28:423-429.
10. Falagas ME, Bliziotis IA. 2007. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int. J. Antimicrob. Agents 29:630-636.
11. Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A. 2008. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int. J. Antimicrob. Agents 32:450-454.
12. Souli M, Galani I, Giamarellou H. 2008. Emergence of extensively drugresistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill. 13(47):pii19045. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId19045.
13. Moffatt JH, Harper M, Adler B, Nation RL, Li J, Boyce JD. 2011. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55:3022-3024.
14. López-Rojas R, Jiménez-Mejías ME, Lepe JA, Pachón J. 2011. Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain. J. Infect. Dis. 204:1147-1148.
15. Ko KS, Suh JY, Kwon KT, Jung S-I, Park Kang K-HCI, Chung DR, Peck KR, Song J-H. 2007. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother. 60:1163-1167.
16. Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53:3628-3634.
17. Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N. 2011. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 55:3370-3379.
18. Park YK, Choi JY, Shin D, Ko KS. 2011. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 37:525-530.
19. López-Rojas R, Domínguez-Herrera J, McConnell MJ, Docobo-Peréz F, Smani Y, Fernández-Reyes M, Rivas L, Pachón J. 2011. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J. Infect. Dis. 203:545-548.
20. Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS, Hancock REW. 2011. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob. Agents Chemother. 55: 3743-3751.
21. Henry R, Vithanage N, Harrison P, Seemann T, Coutts S, Moffatt JH, Nation RL, Li J, Harper M, Adler B, Boyce JD. 2012. Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly--1, 6-Nacetylglucosamine. Antimicrob. Agents Chemother. 56:59-69.
22. Moffatt JH, Harper M, Harrison P, Hale JDF, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD. 2010. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54:4971-4977.
23. Hornsey M, Loman N, Wareham DW, Ellington MJ, Pallen MJ, Turton JF, Underwood A, Gaulton T, Thomas CP, Doumith M, Livermore DM, Woodford N. 2011. Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J. Antimicrob. Chemother. 66:1499-1503.
24. Hood MI, Jacobs AC, Sayood K, Dunman PM, Skaar EP. 2010. Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations. Antimicrob. Agents Chemother. 54:1029-1041.
25. Jacobs AC, Hood I, Boyd KL, Olson PD, Morrison J, Carson S, Sayood K, Iwen PC, Skaar EP, Dunman PM. 2010. Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect. Immun. 78: 1952-1962.
26. Dorsey CW, Tomaras AP, Connerly PL, Tolmasky ME, Crosa JH, Actis LA. 2004. The siderophore-mediated iron acquisition systems of Acinetobacter baumanniiATCC19606 and Vibrio anguillarum 775 are structurally and functionally related. Microbiology 150:3657-3667.
27. Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang Cohoon H-YM, de Crécy-Lagard V, Diaz N, Disz T, Edwards R, Fonstein M, Frank ED, Gerdes S, Glass EM, Goesmann A, Hanson A, Iwata-Reuyl D, Jensen R, Jamshidi N, Krause L, Kubal M, Larsen N, Linke B, McHardy AC, Meyer F, Neuweger H, Olsen G, Olson R, Osterman A, Portnoy V, Pusch GD, Rodionov DA, Rückert C, Steiner J, Stevens R, Thiele I, Vassieva O, Ye Y, Zagnitko O, Vonstein V. 2005. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 33:5691-5702.
28. Fomsgaard A, Freudenberg MA, Galanos C. 1990. Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J. Clin. Microbiol. 28:2627-2631.
29. Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, Blevins JS, Smeltzer MS. 2004. Global gene expression in Staphylococcus aureus biofilms. J. Bacteriol. 186:4665-4684.
30. Diamant S, Eliahu N, Rosenthal D, Goloubinoff P. 2001. Chemical chaperones regulate molecular chaperones in vitro and in cells under combined salt and heat stresses. J. Biol. Chem. 276:39586-39591.
31. Ignatova Z, Gierasch LM. 2006. Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant. Proc. Natl. Acad. Sci. U. S. A. 103:13357-13361.
32. Yancey PH. 2005. Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses. J. Exp. Biol. 208:2819-2830.
33. Luke NR, Sauberan SL, Russo TA, Beanan JM, Olson R, Loehfelm TW, Cox AD, St Michael F, Vinogradov EV, Campagnari AA. 2010. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infect. Immun. 78:2017-2023.
34. Iwashkiw JA, Seper A, Weber BS, Scott NE, Vinogradov E, Stratilo C, Reiz B, Cordwell SJ, Whittal R, Schild S, Feldman MF. 2012. Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. PLoS Pathog. 8:e1002758. doi:10.1371/journal.ppat.1002758.
35. Boyce JD, Harper M, St Michael F, John M, Aubry A, Parnas H, Logan SM, Wilkie IW, Ford M, Cox AD, Adler B. 2009. Identification of novel glycosyltransferases required for assembly of the Pasteurella multocida A:1 lipopolysaccharide and their involvement in virulence. Infect. Immun. 77:1532-1542.
36. March C, Regueiro V, Llobet E, Moranta D, Morey P, Garmendia J, Bengoechea JA. 2010. Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response. PLoS One 5:e10033. doi:10.1371/journal.pone.0010033.
37. Liechty A, Chen J, Jain MK. 2000. Origin of antibacterial stasis by polymyxin B in Escherichia coli. Biochim. Biophys. Acta 1463:55-64.
38. Oh JT, Cajal Y, Skowronska EM, Belkin S, Chen J, Van Dyk TK, Sasser M, Jain MK. 2000. Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli. Biochim. Biophys. Acta 1463:43-54.
39. Oh JT, Van Dyk TK, Cajal Y, Dhurjati PS, Sasser M, Jain MK. 1998. Osmotic stress in viable Escherichia coli as the basis for the antibiotic response by polymyxin B. Biochem. Biophys. Res. Commun. 246:619-623.
40. Dorsey CW, Tomaras AP, Actis LA. 2002. Genetic and phenotypic analysis of Acinetobacter baumannii insertion derivatives generated with a transposome system. Appl. Environ. Microbiol. 68:6353-6360.